LEUNG GABRIEL - 05 Aug 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
/s/ Steven Robbins, Attorney in fact for Kinyip Gabriel Leung
Issuer symbol
NVCR
Transactions as of
05 Aug 2021
Transactions value $
-$121,050
Form type
4
Filing time
06 Aug 2021, 16:39:02 UTC
Previous filing
08 Jul 2021
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Options Exercise $31.5K +1K +1.37% $31.45 73.9K 05 Aug 2021 Direct F1
transaction NVCR Ordinary Shares Sale -$153K -1K -1.35% $152.50 72.9K 05 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1K -29.9% $0.00 2.35K 05 Aug 2021 Ordinary Shares 1K $31.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung.
F2 Fully vested as of the date hereof.